Clinical Trials Browser

Prostate Cancer Metastatic × LY3023414 × Clear all

NCT02407054 2021-05-11

A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer

Phase 2 Completed

142 enrolled 16 charts

Prostate Cancer Metastatic